相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Gene Expression Analysis of Mevalonate Kinase Deficiency Affected Children Identifies Molecular Signatures Related to Hematopoiesis
Simona Pisanti et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
The TRAIL in the Treatment of Human Cancer: An Update on Clinical Trials
Martin Snajdauf et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Histone Deacetylase Inhibitors in Pediatric Brain Cancers: Biological Activities and Therapeutic Potential
Alexandre Perla et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Heterochromatin: an epigenetic point of view in aging
Jong-Hyuk Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Overcoming Immune Evasion in Melanoma
Kevinn Eddy et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Multiple Interactions Between Cancer Cells and the Tumor Microenvironment Modulate TRAIL Signaling: Implications for TRAIL Receptor Targeted Therapy
Margot de Looff et al.
FRONTIERS IN IMMUNOLOGY (2019)
y Epigenetic Regulation of TRAIL Signaling: Implication for Cancer Therapy
Mohammed I. Y. Elmallah et al.
CANCERS (2019)
Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment
Monica Marzagalli et al.
SEMINARS IN CANCER BIOLOGY (2019)
NEDD4 Negatively Regulates GITR via Ubiquitination in Immune Microenvironment of Melanoma
Yu Guo et al.
ONCOTARGETS AND THERAPY (2019)
Implications of Cellular Aging in Cardiac Reprogramming
Fabiana Passaro et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2018)
Role of ZNF224 in cell growth and chemoresistance of chronic lymphocitic leukemia
Teresa Busiello et al.
HUMAN MOLECULAR GENETICS (2017)
Histone Deacetylase Inhibitors as Anticancer Drugs
Tomas Eckschlager et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Targeted agents and immunotherapies: optimizing outcomes in melanoma
Jason J. Luke et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
A regulatory role for the co-chaperone FKBP51s in PD-L1 expression in glioma
Paolo D'Arrigo et al.
Oncotarget (2017)
Immune system and melanoma biology: a balance between immunosurveillance and immune escape
Anna Passarelli et al.
ONCOTARGET (2017)
FKBP51 employs both scaffold and isomerase functions to promote NF-κB activation in melanoma
Simona Romano et al.
NUCLEIC ACIDS RESEARCH (2015)
Trailing TRAIL resistance: novel a gets for TRAIL sensitization in cancer cells
Rachana Trivedi et al.
FRONTIERS IN ONCOLOGY (2015)
Histone Deacetylase Inhibitor Sensitizes Apoptosis-Resistant Melanomas to Cytotoxic Human T Lymphocytes through Regulation of TRAIL/DR5 Pathway
Ali R. Jazirehi et al.
JOURNAL OF IMMUNOLOGY (2014)
FK506 binding protein 51 positively regulates melanoma stemness and metastatic potential
S. Romano et al.
CELL DEATH & DISEASE (2013)
Epigenetic modifications in cancer
R. Kanwal et al.
CLINICAL GENETICS (2012)
Role of FK506-binding protein 51 in the control of apoptosis of irradiated melanoma cells
S. Romano et al.
CELL DEATH AND DIFFERENTIATION (2010)
Thapsigargin sensitizes human melanoma cells to TRAIL-induced apoptosis by up-regulation of TRAIL-R2 through the unfolded protein response
Li Hua Chen et al.
CARCINOGENESIS (2007)
GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations
S Ronchetti et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-κB and inhibition of Bcl-xL expression
S Huerta-Yepez et al.
ONCOGENE (2004)
Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development
K Takeda et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
How melanoma cells evade trail-induced apoptosis
P Hersey et al.
NATURE REVIEWS CANCER (2001)
Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells
K Takeda et al.
NATURE MEDICINE (2001)
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems
H Walczak et al.
EXPERIMENTAL CELL RESEARCH (2000)
分享论文
